Treatment of Gonorrhoea with Cefotiam: Activity in vitro and Clinical Results of a 1-Gram Single-Dose Regimen
- 1 January 1985
- journal article
- research article
- Published by S. Karger AG in Dermatology
- Vol. 171 (4) , 264-268
- https://doi.org/10.1159/000249435
Abstract
Cefotiam is clearly more active against Neisseria gonorrhoeae in vitro than penicillin. This applies especially to strains producing beta-lactamase but also to those which do not. No strain requires more than 0.25 μg/ml for inhibition. 1 g of cefotiam dissolved in 3 ml of 1% lidocaine solution cures 90.0% of patients suffering from uncomplicated genital gonorrhoea if injected once intramuscularly. Tolerance of this regimen is very good, no major side-effect being found.Keywords
This publication has 3 references indexed in Scilit:
- Plasma and Skin Blister Fluid Levels of Cefotiam and Cefmenoxime after Single Intramuscular Application of 1 g in GonorrheaChemotherapy, 1984
- Susceptibility of Neisseria gonorrhoeae to Ceftizoxime in vitro and in vivoChemotherapy, 1984
- Susceptibility of neisseria gonorrhoeae to cefotaxime: in vitro studies and treatment resultsArchives of Dermatological Research, 1982